首页> 外国专利> A METHOD FOR OPTIMIZING IMMUNE ACTIVITY IN THE TREATMENT OF AUTO-IMMUNE DISEASES AND CHRONIC IMMUNE CONDITIONS

A METHOD FOR OPTIMIZING IMMUNE ACTIVITY IN THE TREATMENT OF AUTO-IMMUNE DISEASES AND CHRONIC IMMUNE CONDITIONS

机译:在自发性疾病和慢性免疫疾病治疗中优化免疫活性的方法

摘要

A method and composition for optimizing immune activity in the treatment of chronic immune conditions wherein the chronic immune conditions is Hepatitis-C. A method and composition is described for reducing the inflammation and the viral activity in the hepatocytes in living mammals, and for reducing the number of carcinogenic free radicals including hydroxyl and super oxide anions in living mammals, and for enhancing the immune system in HIV/Aids infected individuals by enhancing the bodily mechanisms including intracellular communication, gene regulation, gene repair and membrane effects. A method and composition for optimizing immune activity under conditions of chronic immune conditions in the treatment of such chronic immune conditions wherein the chronic immune conditions include Hepatitis-C, Cancer, AIDS/HIV, Herpes, Colds, Influenza, Bronchitis, Chronic fatigue and Epstein Barr. The term Chronic Immune Conditions is defined to include the following diseases, namely Cancer, AIDS/HIV, Hepatitis-C, Herpes, Colds, Influenza, Bronchitis, Chronic fatigue and Epstein Barr. A method and composition for optimizing immune activity, which comprises administering to the mammal a safe and effective daily maximum amount of a mixture of: a) inositol hexaphosphate or a physiologically acceptable salt thereof; b) inositol or a physiologically acceptable salt thereof; c) N-Acetyl Cysteine; d) Alpha Lipoic Acid; and e) a combination of beta-sitosterol and beta-sitosterolin, in the ratio of weight in milligrams of (a):(b):(c):(d), (e) from about 8000 to 10000 milligrams of (a), from about 80 to 250 milligrams of (b), from about 200 to 1500 milligrams of (c), from about 50 to 300 milligrams of (d), and from 5 to 50 milligrams of (e).
机译:在慢性免疫疾病的治疗中用于优化免疫活性的方法和组合物,其中所述慢性免疫疾病是丙型肝炎。描述了一种方法和组合物,其用于减少活体哺乳动物的肝细胞中的炎症和病毒活性,以及​​减少活体哺乳动物中的致癌自由基(包括羟基和超氧化物阴离子)的数目,并用于增强HIV /艾滋病的免疫系统通过增强包括细胞内通讯,基因调控,基因修复和膜效应在内的身体机制来感染个体。在这类慢性免疫疾病的治疗中用于优化慢性免疫疾病条件下的免疫活性的方法和组合物,其中所述慢性免疫疾病包括丙型肝炎,癌症,AIDS / HIV,疱疹,感冒,流感,支气管炎,慢性疲劳和爱泼斯坦巴尔术语“慢性免疫疾病”定义为包括以下疾病,即癌症,艾滋病/艾滋病毒,丙型肝炎,疱疹,感冒,流行性感冒,支气管炎,慢性疲劳和爱泼斯坦巴尔。用于优化免疫活性的方法和组合物,其包括每天给哺乳动物安全有效的最大量的混合物:a)六磷酸肌醇或其生理学上可接受的盐; b)肌醇或其生理上可接受的盐; c)N-乙酰半胱氨酸; d)α-硫辛酸; e)β-谷甾醇和β-谷甾醇的组合,其重量比为(a):( b):( c):( d),(e)毫克计(8000)至10000毫克(a) ),约80至250毫克(b),约200至1500毫克(c),约50至300毫克(d)和5至50毫克(e)。

著录项

  • 公开/公告号WO0100194A3

    专利类型

  • 公开/公告日2001-12-20

    原文格式PDF

  • 申请/专利权人 JACOBS ROBERT H.;

    申请/专利号WO2000IB00791

  • 发明设计人 JACOBS ROBERT H.;

    申请日2000-06-13

  • 分类号A61K31/683;

  • 国家 WO

  • 入库时间 2022-08-22 00:38:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号